Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function

Wuyts WA, Azuma A, Distler J, Sondergaard K, Proudman S, Cottin V, Erhardt E, Quaresma M, Gahlemann M, Alves M, Maher TM (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

European Respiratory Journal European Respiratory Society

Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTD

City/Town: SHEFFIELD

Conference Proceedings Title: EUROPEAN RESPIRATORY JOURNAL

DOI: 10.1183/13993003.congress-2020.3393

Authors with CRIS profile

Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

Involved external institutions

Royal Adelaide Hospital

Australia (AU) Boehringer Ingelheim Schweiz

Switzerland (CH) mainanalytics GmbH

Germany (DE) Université Claude Bernard Lyon 1 (UCB)

France (FR) Boehringer Ingelheim Pharma GmbH & Co. KG

Germany (DE) Imperial College London / The Imperial College of Science, Technology and Medicine

United Kingdom (GB) Nippon Medical School

Japan (JP) University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven

Belgium (BE) Aarhus University Hospital / Aarhus Universitetshospital

Denmark (DK)

How to cite

APA:

Wuyts, W.A., Azuma, A., Distler, J., Sondergaard, K., Proudman, S., Cottin, V.,... Maher, T.M. (2020). Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function. In EUROPEAN RESPIRATORY JOURNAL. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD.

MLA:

Wuyts, Wim A., et al. "Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function." Proceedings of the EUROPEAN RESPIRATORY JOURNAL SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD, 2020.

BibTeX: Download